New Pancreatic Cancer Drug Extends Patient Survival

A breakthrough drug called daraxonrasib has shown it can extend survival in pancreatic cancer patients, one of medicine's toughest challenges.

The announcement from Revolution Medicines marks what experts are calling a new era in treating this devastating disease.